Navigation Links
Salimetrics Launches a Better Salivary IL-6 ELISA/EIA Kit
Date:9/5/2013

State College, PA (PRWEB) September 05, 2013

Salimetrics has completed the development of a new, fully validated assay kit for the measurement of interleukin-6 (IL-6) in saliva samples. The Salimetrics IL-6 assay is the only assay designed and validated specifically for the accurate measurement of IL-6 in saliva. Salimetrics is leading the cutting-edge of salivary research by providing premium assays for inflammatory and immune related markers, which researchers can add to their studies alongside the well-respected assays for stress hormones, sex hormones, and autonomic markers that researchers trust to deliver precise and consistent results.

In addition to the IL-6 assay, Salimetrics offers additional salivary immunoassay kits related to inflammation and immunity: IL-1 Beta, C-reactive protein, and secretory IgA. Salivary inflammatory markers for TNF-Alpha are currently available through The Salimetrics Laboratory, while a commercially available immunoassay is currently under development.

IL-6 is a key inflammatory signaling molecule released after infection, injury, or antigenic challenge, and is widely used as a biomarker of systemic inflammation. Circulating IL-6 is primarily released from immune cells, but it is also secreted from a wide variety of other tissues. IL-6 is also present in saliva due to production by immune cells, various oral tissues, and cells in the saliva glands.

The latest research suggests that salivary levels of interleukin-6 and other cytokines respond to psychological stress or antigenic challenges outside the oral cavity in a fashion similar to that seen in circulation. This research advises that circulating and oral levels of these markers may be influenced by similar autonomic signaling pathways. The relevance of IL-6 in saliva and GCF (gingival crevicular fluid) to the etiology of periodontitis or other oral diseases is well established in the literature, while further studies are required to explore the relationships of IL-6 and other cytokines in saliva to systemic inflammation and diseases outside the mouth. IL-6 signaling also contributes to periodontal disease pathology as a mediator of bone resorption by directly stimulating osteoclast differentiation.

Researchers interested in learning more about the Salimetrics salivary IL-6 immunoassay kit or incorporating IL-6 into their research project can find support through the Salimetrics website or by e-mailing support(at)salimetrics(dot)com.

About Salimetrics:

Founded in 1998, Salimetrics, LLC supports researchers, the immunodiagnostic industry, and functional testing laboratories around the world with innovative salivary immunoassay products and services. Salimetrics’ assay kits and CLIA-certified testing services measure biomarkers related to stress, behavior and development, inflammation, and immune function, including: alpha-amylase, androstenedione, blood contamination, chromogranin A, cortisol, cotinine, C-reactive protein, DHEA, DHEA-S, estradiol, estriol, estrone, IL-1b, IL-6, melatonin, progesterone, 17a-hydroxyprogesterone, secretory IgA, testosterone, and TNF-a. Salimetrics also provides salivary DNA analysis. The company is based in State College, Pennsylvania, with offices in the UK and distributors around the world. For more information, visit Salimetrics on the web at http://www.salimetrics.com.

Read the full story at http://www.prweb.com/releases/salivary_EIA_kit/salimetrics_assays/prweb11091609.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Quality Salivary Research with the Salimetrics Center of Excellence Program
2. Salimetrics Offers New Saliva Collection Aid for Easy Collection of Passive Drool Samples
3. Salimetrics to Present Workshop on the Integration of Salivary Analytes into Scientific Studies at the Society for Research in Child Development (SRCD) Preconference
4. Full Service CRO DAaCRO Joins Salimetrics Center of Excellence Program
5. Salimetrics Launches a Faster, More Accurate, Salivary Melatonin Assay
6. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
7. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
8. BioLife Solutions Launches Search Engine Optimized Website and 1,000 Free Samples Offer
9. Ambry Genetics Launches Illumina MiSeq Next-Gen Sequencing Services
10. Neogen Launches Fully Quantitative Lateral Flow Test for DON
11. Exagen Diagnostics Launches Cutting-Edge Lupus Diagnostic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... 2017   Boston Biomedical , an industry leader ... cancer stemness pathways, will feature data from two clinical ... 2017 ASCO Gastrointestinal Cancers Symposium, held from January 19-21, ... Napabucasin is an orally-administered investigational agent designed to ... Cancer stem cells (CSCs) possess the property of stemness ...
(Date:1/18/2017)...   Parent Project Muscular Dystrophy (PPMD) , a ... muscular dystrophy (Duchenne) , today announced a $600,000 grant ... Technology (NJIT) and Talem Technologies (Talem) as part of ... to assist people living with Duchenne. PPMD is funding ... embedded computer, software, a force sensor and a motor ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... Dante Leven successfully implanted SpineFrontier’s A-CIFT™ Solofuse-P™. The operation took place on Wednesday, ... Stream, NY. The procedure was an anterior cervical discectomy and fusion on a ...
(Date:1/18/2017)... Frederick, Maryland (PRWEB) , ... January 18, 2017 ... ... of two new federally funded bio-focused Manufacturing Innovation Institutes (MII). U.S. Secretary of ... Innovation in Manufacturing Biopharmaceuticals (NIIMBL), and the Department of Defense has announced the ...
Breaking Biology Technology:
(Date:1/18/2017)... , Jan. 18, 2017  In vitro diagnostic (IVD) ... mergers and acquisitions (M&A), and Kalorama Information expects that ... acquisitions have been shifting. Generally, uncertainty in reimbursement and ... the U.S. has changed the acquisitions landscape. Instead of ... in companies buying partners outside of their home country ...
(Date:1/12/2017)... NEW YORK , Jan. 12, 2017  New research ... around the office of the future.  1,000 participants were simply ... last three months which we may consider standard issue.  Insights ... office of 2017 were also gathered from futurists and industry ... and Dr. James Canton .  Some ...
(Date:1/6/2017)... , Jan. 6, 2017  Privately-held CalciMedica, Inc., ... in healthy volunteers of a novel calcium release-activated ... acute pancreatitis. Acute pancreatitis, sudden ... mild disorder, but can be very serious.  In severe ... sepsis, where extended hospital stays, time in the ...
Breaking Biology News(10 mins):